Integer's RadialSeal Introducer Kit Receives FDA and CE Mark Approvals

 

July 31, 2018—Integer Holdings Corporation, an outsource manufacturer, announced that it has received United States FDA and European CE Mark approvals for the RadialSeal radial access introducer. Integer's portfolio of access devices is available for distribution by medical device companies in the interventional cardiology and peripheral vascular markets.

According to the company, the RadialSeal introducer kit is founded on Integer's core technology platforms in guidewires and hemostatic introducers. The RadialSeal features a thin-walled sheath design that minimizes outer diameter while maximizing inner diameter and provided ease of sheath insertion through smooth transitions and a hydrophilic coating.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.